Armed with $100M grant, ElevateBio looks to create biomanufacturing center with the University of Pittsburgh
While Pittsburgh has a rich manufacturing history, one biotech is looking to make the city more than just a steel powerhouse.
David Hallal’s ElevateBio, which has managed to build out an impressive war chest of funds over the past few years, will see its latest move partnering with a university to create a biomanufacturing site.
In an announcement Thursday, ElevateBio and the University of Pittsburgh say they’ve signed a 30-year deal for ElevateBio to manufacture cell and gene therapies in Pittsburgh. The agreement will have ElevateBio locate its BaseCamp and GMP manufacturing facilities in the city, with the site eventually running gene editing, induced pluripotent stem cell (iPSC) and cell, vector and protein engineering efforts.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.